作者
Fariba Khodagholi,Niloufar Ansari,Solaleh Khoramian Tusi,Mohsen Amini,Azim Dehghan Amirabad
摘要
Increased oxidative stress is a widely accepted factor in the development and progression of Alzheimer's disease (AD) and the ability of cells to control the balance between the generation and quenching of reactive oxygen species is important in combating its potentially damaging effects. Moreover, in order for drugs to be effective in the treatment of neurodegenerative diseases, they must be capable of penetrating the blood-brain barrier (BBB), whereas more than 98% of all potential CNS drugs don't cross. Here we wished to examine whether 3-thioethyl-5,6-(dichlorophenyl)-1,2,4-triazine has neuroprotective effect and the ability of penetrating the BBB. Using NGF-differentiated PC12 cells, the levels of Nrf2, NF-κB, Caspase-3 and antioxidant enzymes were determined after stress (H2O2 and/or LPS) in the presence and/or absence of this compound. In H2O2 and/or LPS-induced cells, Nrf2, GSH, SOD and CAT were decreased compared to control significantly. In the same time, NF-κB, HSP-90, caspase-3 and MDA were increased. Pretreatment with this 1,2,4-triazine derivative caused a significant increase in the level of Nrf2, HO-1, γ-GCS, GSH, SOD and CAT in H2O2 and/or LPS-induced cells. Concomitantly NF-κB, HSP-90, caspase-3 and MDA levels were decreased which shows its neuroprotective effect through its ability to initiate phase 2 gene, concomitantly, increase of GSH level, CAT and SOD activities and decrease of MDA level and inhibition of NF-κB. Moreover, ANN result showed this compound has good permeability value (0.93) comparing with logBB<-8.0 of impermeable compounds that indicate this compound has the ability of penetrating the BBB. This compound can be suitable candidates for AD because of 1) Its neuroprotective effect. 2) Ability to pass BBB.